June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success
May 27, 2025 How much does a Turkish passport cost?
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
Fulcrum Therapeutics (FULC) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: June 18, 2025 (14:37)
Sector: HealthcareThe share price of Fulcrum Therapeutics, Inc. (FULC) now
Are you interested in Fulcrum Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Fulcrum Therapeutics stock price in 2025, 2026, 2027. How much will one Fulcrum Therapeutics share be worth in 2025 - 2027?
When should I take profit in Fulcrum Therapeutics stock? When should I record a loss on Fulcrum Therapeutics stock? What are analysts' forecasts for Fulcrum Therapeutics stock? What is the future of Fulcrum Therapeutics stock? We forecast Fulcrum Therapeutics stock performance using neural networks based on historical data on Fulcrum Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Fulcrum Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Fulcrum Therapeutics shares. This happens once a day.
Historical and forecast chart of Fulcrum Therapeutics stock
The chart below shows the historical price of Fulcrum Therapeutics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Fulcrum Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Fulcrum Therapeutics is a biopharmaceutical company that develops drugs to treat genetic diseases. The company has developed product candidates to modulate gene expression and potentially treat the underlying cause of these diseases.
Fulcrum Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun 20 | 6.63 | 6.46 | 6.73 | 4.11 |
| Jun 21 | 6.69 | 6.62 | 6.90 | 4.24 |
| Jun 22 | 6.73 | 6.56 | 6.88 | 4.76 |
| Jun 23 | 6.54 | 6.41 | 6.65 | 3.67 |
| Jun 24 | 6.73 | 6.60 | 6.82 | 3.39 |
| Jun 25 | 6.87 | 6.79 | 7.04 | 3.60 |
| Jun 26 | 6.94 | 6.87 | 7.02 | 2.22 |
| Jun 27 | 7.07 | 6.87 | 7.21 | 4.85 |
| Jun 28 | 7.23 | 7.06 | 7.44 | 5.36 |
| Jun 29 | 7.10 | 6.96 | 7.19 | 3.35 |
| Jun 30 | 7.10 | 7.03 | 7.17 | 1.98 |
| Jul 01 | 7.11 | 7.01 | 7.24 | 3.28 |
| Jul 02 | 7.33 | 7.11 | 7.55 | 6.10 |
| Jul 03 | 7.51 | 7.44 | 7.66 | 3.07 |
| Jul 04 | 7.37 | 7.31 | 7.55 | 3.35 |
| Jul 05 | 7.36 | 7.17 | 7.46 | 4.06 |
| Jul 06 | 7.32 | 7.26 | 7.55 | 4.04 |
| Jul 07 | 7.41 | 7.20 | 7.53 | 4.57 |
| Jul 08 | 7.27 | 7.12 | 7.46 | 4.70 |
| Jul 09 | 7.26 | 7.11 | 7.35 | 3.39 |
| Jul 10 | 7.14 | 6.99 | 7.30 | 4.37 |
| Jul 11 | 7.10 | 6.95 | 7.22 | 3.88 |
| Jul 12 | 7.34 | 7.27 | 7.52 | 3.39 |
| Jul 13 | 7.26 | 7.03 | 7.41 | 5.37 |
| Jul 14 | 7.47 | 7.25 | 7.67 | 5.77 |
| Jul 15 | 7.37 | 7.29 | 7.52 | 3.15 |
| Jul 16 | 7.51 | 7.44 | 7.64 | 2.70 |
| Jul 17 | 7.49 | 7.39 | 7.57 | 2.43 |
| Jul 18 | 7.32 | 7.17 | 7.55 | 5.31 |
| Jul 19 | 7.30 | 7.21 | 7.47 | 3.52 |
Fulcrum Therapeutics Daily Price Targets
Fulcrum Therapeutics Stock Forecast 06-20-2025.
Forecast target price for 06-20-2025: $6.63.
Positive dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 3.943%.
Pessimistic target level: 6.46
Optimistic target level: 6.73
Fulcrum Therapeutics Stock Forecast 06-21-2025.
Forecast target price for 06-21-2025: $6.69.
Positive dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 4.070%.
Pessimistic target level: 6.62
Optimistic target level: 6.90
Fulcrum Therapeutics Stock Forecast 06-22-2025.
Forecast target price for 06-22-2025: $6.73.
Positive dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 4.540%.
Pessimistic target level: 6.56
Optimistic target level: 6.88
Fulcrum Therapeutics Stock Forecast 06-23-2025.
Forecast target price for 06-23-2025: $6.54.
Negative dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 3.542%.
Pessimistic target level: 6.41
Optimistic target level: 6.65
Fulcrum Therapeutics Stock Forecast 06-24-2025.
Forecast target price for 06-24-2025: $6.73.
Positive dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 3.277%.
Pessimistic target level: 6.60
Optimistic target level: 6.82
Fulcrum Therapeutics Stock Forecast 06-25-2025.
Forecast target price for 06-25-2025: $6.87.
Positive dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 3.475%.
Pessimistic target level: 6.79
Optimistic target level: 7.04
FULC (FULC) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul. | 7.78 | 6.85 | 9.01 | 24.01 |
| Aug. | 8.68 | 7.83 | 10.02 | 21.84 |
| Sep. | 8.89 | 7.88 | 9.62 | 18.11 |
| Oct. | 9.14 | 8.15 | 9.65 | 15.53 |
| Nov. | 9.53 | 8.86 | 10.94 | 18.99 |
| Dec. | 8.93 | 8.06 | 9.56 | 15.70 |
Fulcrum Therapeutics forecast for this year
Fulcrum Therapeutics Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $7.78128. Pessimistic: $6.85. Optimistic: $9.01
Fulcrum Therapeutics Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $8.68391. Pessimistic: $7.83. Optimistic: $10.02
Fulcrum Therapeutics Stock Prediction for Sep 2025
An uptrend is forecast for this month with an optimal target price of $8.89232. Pessimistic: $7.88. Optimistic: $9.62
Fulcrum Therapeutics Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $9.14131. Pessimistic: $8.15. Optimistic: $9.65
Fulcrum Therapeutics Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $9.52524. Pessimistic: $8.86. Optimistic: $10.94
Fulcrum Therapeutics Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $8.93468. Pessimistic: $8.06. Optimistic: $9.56
Fulcrum Therapeutics (FULC) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 10.54 | 9.11 | 11.15 | 18.34 |
| Feb | 10.67 | 10.01 | 11.72 | 14.57 |
| Mar | 11.35 | 10.08 | 11.92 | 15.43 |
| Apr | 11.35 | 10.15 | 12.76 | 20.46 |
| May | 12.28 | 10.64 | 13.02 | 18.30 |
| Jun | 10.69 | 10.02 | 11.67 | 14.10 |
| Jul | 10.94 | 10.42 | 11.99 | 13.14 |
| Aug | 12.91 | 11.75 | 13.66 | 13.99 |
| Sep | 14.77 | 12.53 | 16.90 | 25.87 |
| Oct | 13.80 | 13.16 | 15.20 | 13.43 |
| Nov | 13.69 | 12.81 | 15.08 | 15.06 |
| Dec | 16.10 | 15.13 | 17.29 | 12.48 |
Fulcrum Therapeutics (FULC) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 16.87 | 15.86 | 18.93 | 16.22 |
| Feb | 15.38 | 13.08 | 16.92 | 22.73 |
| Mar | 15.01 | 13.75 | 16.07 | 14.39 |
| Apr | 16.34 | 15.29 | 17.45 | 12.36 |
| May | 13.92 | 13.14 | 15.39 | 14.65 |
| Jun | 12.67 | 10.64 | 13.17 | 19.23 |
| Jul | 12.54 | 10.61 | 14.44 | 26.56 |
| Aug | 14.24 | 13.67 | 14.98 | 8.74 |
| Sep | 15.24 | 13.81 | 16.70 | 17.34 |
| Oct | 13.26 | 11.27 | 14.82 | 23.97 |
| Nov | 14.43 | 13.73 | 16.30 | 15.75 |
| Dec | 12.55 | 11.02 | 13.25 | 16.86 |
Fulcrum Therapeutics information and performance
26 LANDSDOWNE STREET, CAMBRIDGE, MA, US
Market capitalization of the Fulcrum Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of FULC shares in the company outstanding by the market price of one share.
EBITDA of Fulcrum Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Fulcrum Therapeutics Stock)
Should I Buy Fulcrum Therapeutics Shares in 2025 year?
Does Fulcrum Therapeutics pay dividends?
Which economic sector do Fulcrum Therapeutics's shares belong to?
Which other securities belong to the same sector as Fulcrum Therapeutics's shares?
